These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22978170)

  • 1. [The application of single-genome amplification and sequencing in genomic analysis of an attenuated EIAV vaccine].
    Wei HM; Wang XF; Wang SS; Du C; Liu HF; Liu Q; Zhou JH
    Bing Du Xue Bao; 2012 Jun; 28(4):431-8. PubMed ID: 22978170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of proviral genomes between the Chinese EIAV donkey leukocyte-attenuated vaccine and its parental virulent strain].
    Wang XF; Jiang CG; Guo W; Xiang W; Lv XL; Zhao LP; Wang FL; Kong XG; Zhang XY; Shao YM; Zhou JH
    Bing Du Xue Bao; 2008 Nov; 24(6):443-50. PubMed ID: 19226953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of EIAV
    Liu C; Wang XF; Wang Y; Chen J; Zhong Z; Lin Y; Wang X
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31022927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J
    Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.
    Qi X; Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Shen R; Wang F; Kong X; Su Z; Zhou J
    Virus Genes; 2010 Aug; 41(1):86-98. PubMed ID: 20526660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
    Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
    J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies
    Wang XF; Liu Q; Wang YH; Wang S; Chen J; Lin YZ; Ma J; Zhou JH; Wang X
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the correlation between the plasma viral load and protective immunity induced by the equine infectious anemia attenuated vaccine and its parental virulent strain].
    Cao XZ; Lin YZ; Li L; Jiang CG; Zhao LP; Lv XL; Zhou JH
    Bing Du Xue Bao; 2010 Mar; 26(2):128-33. PubMed ID: 20480642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
    Leroux C; Issel CJ; Montelaro RC
    J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
    Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
    Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
    Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W
    Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and in vitro evaluation of an infectious clone of the equine infectious anemia virus vaccine strain EIAV(FDDV) with four reverse-mutated vaccine-specific sites in the S2 gene].
    Gao X; Jiang CG; Han XE; Zhao LP; Shen RX; Xiang WH; Zhou JH
    Bing Du Xue Bao; 2009 Jul; 25(4):309-15. PubMed ID: 19769166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Envelope determinants of equine lentiviral vaccine protection.
    Craigo JK; Ezzelarab C; Cook SJ; Chong L; Horohov D; Issel CJ; Montelaro RC
    PLoS One; 2013; 8(6):e66093. PubMed ID: 23785473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
    Jin S; Issel CJ; Montelaro RC
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1120-9. PubMed ID: 15539516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
    Han X; Zhang P; Yu W; Xiang W; Li X
    Virus Genes; 2016 Dec; 52(6):814-822. PubMed ID: 27572122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity.
    Ma J; Shi N; Jiang CG; Lin YZ; Wang XF; Wang S; Lv XL; Zhao LP; Shao YM; Kong XG; Zhou JH; Shen RX
    Virology; 2011 Feb; 410(1):96-106. PubMed ID: 21094511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.